Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 20 March 2026
Accepted: 11 April 2026
First Online: 27 April 2026
Declarations
:
: SDR has received speaker fees from Aferetica, Estor, Toray, Vantive, and Alexion. All other authors declare no conflicts of interest. ML is supported by grant R01-GM151494-01 and R01DK139484-01 from the NIH. Dr. Legrand reports consulting fees from Viatris, Pharmazz Inc, Vantive, Idorsia, Estor and OceaneX. MJ has received grants from Baxter/Vantive and Fresenius, consulting fees from Baxter/Vantive, AmPharma, Biomerieux, SphingoTec and Novartis as well as lecture fees from Baxter, Biomerieux and AOP and is a board member of the International Society of Critical Care Nephrology (ISCCN).
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.
